skip to main content




Back to all Representative Matters
May 26, 2017

Cheticamp Fisheries Completes Sale to Quebec-Based Private Equity Firm

Joel M. Rose, Joanne C. Coldwell, Barbara Worndl, Jesse Rosensweet, Lorenzo Lisi, Fiona Brown and Ken Clark

Pêcheries Cheticamp Fisheries Intl. (2016) Ltd. announced the completion of its acquisition by Champlain Financial Corporation, headquartered in Montreal, Quebec. Cheticamp Fisheries is a prominent seafood processor located on Cape Breton Island, Nova Scotia, supplying premium snow crab and lobster to customers in North America and Asia.

Aird & Berlis LLP represented Cheticamp Fisheries in this M&A transaction. A&B’s team was led by Joel Rose and Joanne Coldwell, and included Barbara Worndl (tax), Jesse Rosensweet (corporate and regulatory), Lorenzo Lisi and Fiona Brown (labour and employment) and Ken Clark (intellectual property).

Related Representative Matters

Representative Matters
Fluent, Inc. Completes Acquisition of AdParlor Holdings, Inc. Peter K. Czegledy, Francesco Gucciardo, Barbra H. Miller, Sam Billard, Ken Clark, John J. Longo, Stephen Zolf and Saam Nainifard Jul 03, 2019 Fluent, Inc. (“Fluent”), a leading data-driven performance marketing company, signed a definitive agreement to acquire AdParlor Holdings, Inc. ("AdParlor") and its group of companies.
Representative Matters
Allied Properties REIT Completes $345 Million Public Equity Offering Margaret T. Nelligan, Sherri M. Altshuler, Anne E. Miatello, Melanie Cole, Liam Tracey-Raymont, Amy Marcen-Gaudaur, Michael D. Smith, Neill Kalvin, Zale Skolnik and Barbara Worndl Jun 24, 2019 Allied Properties Real Estate Investment Trust, a leading owner, manager and developer of distinctive urban workspace in Canada’s major cities and network-dense urban data centres in Toronto that form Canada’s hub for global connectivity, recently completed a $345 million public equity offering o...
Representative Matters
MediPharm Labs Completes $75 Million Bought Deal Financing Melanie Cole, Amy Marcen-Gaudaur, Meredith McCann and Barbara Worndl Jun 18, 2019 MediPharm Labs Corp., a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, recently completed a $75 million bought deal offering of common shares.